Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
200000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 22nd Series Stock Acquisition Rights with Exercise Price Adjustment Clauses issued through a third-party allotment
発行・処分する株式数
Shares delivered during the month: 200,000 shares (200,000 new shares and 0 treasury shares transferred)
Intended allottee
Macquarie Bank Limited (the allottee of the previously issued stock acquisition rights)
発行済株式総数
Exercise ratio subject to exercise restrictions: 1.3% (200,000 shares delivered across all series / 15,899,482 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥148–¥157. Details of the adjustment clauses are Not disclosed in this disclosure.
Exercise period
These stock acquisition rights may be exercised through 14 September 2026, the day before the acquisition date.
Number of Stock Acquisition Rights
Total issued: 89,000; unexercised as of 3 August 2026: 79,799; unexercised as of the end of August 2026: 77,799
Reason for acquisition without consideration
The company resolved to acquire all of these stock acquisition rights on 15 September 2026 and cancel all of them immediately after the acquisition.
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Announced on 21 April 2026: issuance of new shares through a third-party allotment, the 22nd Series of Stock Acquisition Rights with exercise price adjustment clauses, the 23rd Series of Stock Acquisition Rights with exercise price adjustment clauses, and the 24th Series of Stock Acquisition Rights (the respective amounts are Not disclosed in this disclosure)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 22nd Series Stock Acquisition Rights with Exercise Price Adjustment Clauses issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month: 200,000 shares (200,000 new shares and 0 treasury shares transferred) |
| Intended allottee | Macquarie Bank Limited (the allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 1.3% (200,000 shares delivered across all series / 15,899,482 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 17,519,582 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Exercise price | Exercise price during the month: ¥148–¥157. Details of the adjustment clauses are Not disclosed in this disclosure. |
| Exercise period | These stock acquisition rights may be exercised through 14 September 2026, the day before the acquisition date. |
| Number of Stock Acquisition Rights | Total issued: 89,000; unexercised as of 3 August 2026: 79,799; unexercised as of the end of August 2026: 77,799 |
| Reason for acquisition without consideration | The company resolved to acquire all of these stock acquisition rights on 15 September 2026 and cancel all of them immediately after the acquisition. |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Announced on 21 April 2026: issuance of new shares through a third-party allotment, the 22nd Series of Stock Acquisition Rights with exercise price adjustment clauses, the 23rd Series of Stock Acquisition Rights with exercise price adjustment clauses, and the 24th Series of Stock Acquisition Rights (the respective amounts are Not disclosed in this disclosure) |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and no reason for the exercises is stated. The company has resolved to acquire and cancel all of the 22nd and 23rd Series of Stock Acquisition Rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.